On the issue of transparency and reproducibility in nanomedicine

Summary

This correspondence article presents responses from the nanomedicine community on the proposed MIRIBEL (Minimum Information Reporting in Bio–Nano Experimental Literature) checklist aimed at improving transparency and reproducibility. While many contributors support standardized reporting to enhance data quality and clinical translation, others caution that rigid checklists may stifle innovation, ignore material-specific nuances, and place undue burden on academic labs. The debate underscores the challenge of balancing standardization with the need for flexibility in a rapidly evolving field.